pyrazines has been researched along with Ependymoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arnold, LA; Atkinson, JM; Boulos, N; Carcaboso, AM; Eden, C; Ellison, DW; Féau, C; Gajjar, A; Gibson, P; Gilbertson, RJ; Guy, RK; Johnson, RA; Koul, D; Kranenburg, TA; Mohankumar, KM; Phoenix, T; Poppleton, H; Priebe, W; Shelat, AA; Stewart, CF; Tong, Y; Wright, K; Yung, WK; Zhu, L | 1 |
1 other study(ies) available for pyrazines and Ependymoma
Article | Year |
---|---|
An integrated in vitro and in vivo high-throughput screen identifies treatment leads for ependymoma.
Topics: Animals; Boronic Acids; Bortezomib; Brain; Brain Neoplasms; Cell Proliferation; Centrosome; Drug Screening Assays, Antitumor; Ependymoma; Fluorouracil; High-Throughput Screening Assays; Insulin; Mice; Mice, Nude; Neural Stem Cells; Pyrazines; Signal Transduction; Tumor Cells, Cultured | 2011 |